Amanda Matter is a doctor of pharmacy student.
I remember a patient in her early sixties who came to our clinic with subtle memory problems. She lived alone in a rural county, relied on Medicaid, and had been passed between social services and different primary care providers for more than a year. No one had ordered imaging, and there were no neurologists nearby. By the time Alzheimer’s disease was suspected, her window for early intervention had already closed.
Medicare …
More than 78 million Americans rely on Medicaid or CHIP for their health care. Yet many still cannot access FDA-approved digital therapeutics because their state does not include them in covered benefits.
Prescription digital therapeutics (PDTs) are software-based treatments authorized by the FDA. They are delivered through smartphones or tablets and are used to manage conditions such as substance use disorder, ADHD, diabetes, and chronic insomnia. For people who face long …
Get free updates delivered free to your inbox.
